Health Watch: Pfizer seeks FDA approval for fourth vaccination for the elderly and immunocompromised

FAIRBANKS, Alaska (KTVF) - Pfizer is currently seeking approval from the FDA for a fourth COVID-19 vaccination for the elderly and immunocompromised.

According to Dr. Lisa Rabinowitz, Staff Physician with Public Health on the Alaska COVID-19 Vaccine Task Force, this is not an entirely new concept as some residents have already received four doses. “We do already have [boosters] for moderately to severely immunocompromised,” Dr. Rabinowitz explained. “They have three doses in their primary series, followed by a booster which is their fourth dose. So speak with your healthcare provider if you have concerns and think you might fall into that category.”

As the FDA reviews the data to make their decision, some may wonder if additional shots for other parts of the community may be approved in the future.

“I think moving forward, I’ve been impressed with how the FDA has responded by watching the science, following the data to make decisions on whether or not boosters should be rolled out to additional parts of the population, including our younger kids that are currently not authorized for a booster yet,” Dr. Rabinowitz continued. “So more to come on this. I think we’re following the journey just like you are, and looking forward to seeing what guidance will come out of this most recent data review.”

For more updates on the COVID-19 situation in Alaska, the Department of Health and Social Services hosts bi-weekly Echo Meetings that are open to the public.